Mydecine Innovations Group Inc.

DB:0NF0 Stock Report

Market Cap: €225.1k

Mydecine Innovations Group Balance Sheet Health

Financial Health criteria checks 0/6

Mydecine Innovations Group has a total shareholder equity of CA$-15.5M and total debt of CA$6.1M, which brings its debt-to-equity ratio to -39.8%. Its total assets and total liabilities are CA$158.5K and CA$15.6M respectively.

Key information

-39.8%

Debt to equity ratio

CA$6.14m

Debt

Interest coverage ration/a
CashCA$13.61k
Equity-CA$15.45m
Total liabilitiesCA$15.61m
Total assetsCA$158.52k

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: 0NF0 has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Long Term Liabilities: 0NF0 has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Debt to Equity History and Analysis

Debt Level: 0NF0 has negative shareholder equity, which is a more serious situation than a high debt level.

Reducing Debt: 0NF0's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: 0NF0 has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: 0NF0 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 7.8% each year


Discover healthy companies